Use of Antiperspirant Products and Risk of Breast Cancer: A Meta-Analysis of Case-Control Studies.

IF 1.8 4区医学 Q3 ONCOLOGY

Cancer Investigation Pub Date : 2024-10-01 Epub Date: 2024-09-26 DOI:10.1080/07357907.2024.2405864

Thao Thi Kim Trinh, Seung-Kwon Myung, Tien Hoang Tran, Kui Son Choi

引用次数: 0

Abstract

Although several observational studies have reported a link between the use of underarm cosmetic products and the risk of breast cancer, the findings remain inconsistent. This study aimed to investigate these associations using a meta-analysis of observational studies. In the meta-analysis of seven case-control studies, we found no association between the use of underarm antiperspirants or deodorants and the risk of breast cancer (OR = 0.96, 95%CI 0.78-1.17; I² = 60.0%). Further prospective cohort studies that provide a higher level of evidence are warranted to confirm our findings.

查看原文本刊更多论文

使用止汗剂产品与乳腺癌风险：病例对照研究的元分析》（Meta-Analysis of Case-Control Studies）。

虽然有多项观察性研究报告了使用腋下化妆品与乳腺癌风险之间的联系，但研究结果仍不一致。本研究旨在通过对观察性研究进行荟萃分析来调查这些关联。在对七项病例对照研究进行的荟萃分析中，我们发现使用腋下止汗剂或除臭剂与乳腺癌风险之间没有关联（OR = 0.96，95%CI 0.78-1.17；I2 = 60.0%）。为了证实我们的研究结果，有必要进一步开展前瞻性队列研究，以提供更高水平的证据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer Investigation 医学-肿瘤学

CiteScore

3.80

自引率

4.20%

发文量

审稿时长

8.5 months

期刊介绍： Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.